These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4252395)

  • 1. Enzymatic and immunochemical determination of plasminogen and plasmin in different physiological and pathological states.
    Mannucci PM; Stabilini R; Bragotti R; Marasini B; Agostoni A
    J Clin Pathol; 1971 Apr; 24(3):228-33. PubMed ID: 4252395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepant changes in plasminogen by two different assays in patients receiving streptokinase.
    Hysell DC; Smith MR; Brewster PS; Fraker TD
    Am J Clin Pathol; 1988 Aug; 90(2):200-5. PubMed ID: 3134813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple, sensitive method for measuring plasmin and plasminogen activity in plasma.
    Uete T; Shimano N; Morikawa M
    Clin Chem; 1975 Oct; 21(11):1632-7. PubMed ID: 240516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasminogen determination, using a chromogenic tripeptidic substrate (author's transl)].
    Soria J; Soria C; Samama M
    Pathol Biol (Paris); 1976 Dec; 24(10):725-9. PubMed ID: 138119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the reliability of plasminogen measurement employing the proactivator-activator converting method.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):551-65. PubMed ID: 138961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of various streptokinase dosage schedules through quantitative streptokinase, plasminogen and plasmin determinations in the plasma of patients].
    Büchner U; Martin M; Auel H
    Verh Dtsch Ges Inn Med; 1975; 81():1152-5. PubMed ID: 132799
    [No Abstract]   [Full Text] [Related]  

  • 7. The control of plasminogen and plasmin during thrombolytic therapy.
    Blix S
    Acta Med Scand; 1969 Nov; 186(5):479-82. PubMed ID: 4244879
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    Thomas DP; Niewiarowski S; Myers AR; Bloch KJ; Colman RW
    N Engl J Med; 1970 Sep; 283(13):663-8. PubMed ID: 4247823
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzymatic assay for the combined determination of plasmin plus plasminogen in milk: revisited.
    Politis I; Zavizion B; Barbano DM; Gorewit RC
    J Dairy Sci; 1993 May; 76(5):1260-7. PubMed ID: 8505418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunctional plasminogen in full term newborn--study of active site of plasmin.
    Benavent A; Estellés A; Aznar J; Martinez-Sales V; Gilabert J; Fornas E
    Thromb Haemost; 1984 Feb; 51(1):67-70. PubMed ID: 6232730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A quick photometric method for the determination of activable plasminogen and of plasmin].
    Bouvier CA; Berthoud S; Roth M
    Thromb Diath Haemorrh; 1967 May; 17(3-4):452-66. PubMed ID: 4231950
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
    Fischer M
    Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum.
    NORMAN PS
    J Exp Med; 1957 Sep; 106(3):423-37. PubMed ID: 13463252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive fluorometric assay for plasminogen, plasmin, and streptokinase.
    Bell PH; Dziobkowski CT; Englert ME
    Anal Biochem; 1974 Sep; 61(1):200-8. PubMed ID: 4277983
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
    Martin H; Auel H; Riedel C
    Behring Inst Mitt; 1986 Feb; (79):263-71. PubMed ID: 2424424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunochemical study of human plasminogen and plasmin.
    Robbins KC; Summaria L
    Immunochemistry; 1966 Jan; 3(1):29-40. PubMed ID: 4223674
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of endogenous fibrinolysis activation on human plasminogen].
    Platonova TK; Kalashnikov VV; Khvatov VB
    Biull Eksp Biol Med; 1987 Jan; 103(1):59-61. PubMed ID: 2432967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The isolation and characterization of a ternary human plasmin B-chain-streptokinase-plasminogen complex.
    Summaria L; Boreisha I; Barlow GH; Robbins KC
    Thromb Haemost; 1987 Aug; 58(2):772-7. PubMed ID: 2960030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancies between immunological and caseinolytic plasma plasminogen assays in health and hyperfibrinolytic states.
    Musumeci V; Leone G; Bizzi B
    J Clin Pathol; 1974 Oct; 27(10):794-7. PubMed ID: 4279253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analytical methods of study of the system of fibrinolysis (plasminogen proactivators-activators, plasminogen-plasmin, antiplasmins, antiactivators) (literature review)].
    Guseĭnov ChS; Golovastova GI; Gorelova AM; Cherenkova GM; Mikhailova ND
    Lab Delo; 1976; (5):276-83. PubMed ID: 62085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.